# A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers

> **NCT01392820** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** TC-5214
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01392820
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2011-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01392820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01392820, "A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01392820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*